Key clinical point: The preoperative ratio of creatinine and cystatin C estimated glomerular filtration rates (eGFRcre/eGFRcys) can predict overall survival (OS) and recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) undergoing hepatic resection.
Major finding: High eGFRcre/eGFRcys (>1.0025) was significantly associated with worse OS (adjusted hazard ratio [aHR] 4.07; P = .03) and RFS (aHR 2.12; P = .04).
Study details: The data come from a retrospective study that included 157 patients with HCC who underwent curative hepatic resection.
Disclosures: The study was sponsored by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science. The authors reported no conflicts of interest.
Source: Harimoto N et al. The ratio of creatinine and cystatin C estimated glomerular filtration rates as a surrogate marker in patients with hepatocellular carcinoma undergoing hepatic resection. J Hepatobiliary Pancreat Sci. 2022 (May 11). Doi: 10.1002/jhbp.1164